The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hoping we have a big move towards that gap soon.
We’ve got news due pretty much imminently.
sub placing price with director buys. Just need an update now
We’ve had some chunky buys recently but just can’t seem to get any movement. Any thoughts?
Looking better with some chunky buys
Would be nice to get an update Monday and start moving back toward 0.7
Two big delayed buys? About £40ks worth
They look like buys to me anyways ?
Flying back up now
How long has a seller been about and do we know who it is?
10.8 seems like a strong floor
Perhaps not…
I’m hoping for a turnaround here back to 25/30s. Slipping today feel like volume and interest is all over He1 etc
What are your thoughts on the buys near close, 3 lumps of £13k buys.
We’d have to actually get some buy backs for that
Surely to god we’re gonna get more buybacks than £63ks worth…
We better see more than 1 60k buy back, we’ve got 10m in the bank ffs
Nice flurry of buys into close. Glad we bounced right out of that 13p area. If share buybacks do start soon, we clearly move very quick, could see 20p (2p) back pretty soon.
Anyone know when we’re relisting? If ever?
We definitely need some updates now from the BoD what they are going to do going forward
After lots of buys, they slightly lower the ask? What’s going on with that?
How would the buyback fair out for the company and SP?
Sort of confusing? So they’re out?
I had hoped to see a good rise to 12/13 today especially once the obvious non existent funding RNS never happened. We have a good cash position that much is obvious and potential cash cow with the the Juva deal. Seems a TR1 seller surely must be imminent. Hopefully they are nearly out? Can’t think of any reason why this is down with recent news!
Do you not research a stock when you gain a position in it? Or do you simply just read forums? Check the cash burn vs our cash in September. And the interview by our CEO last month saying we are fully funded until later next year. It bongles me people believe rumours without researching themselves. Typical aim investors.
You do realise EVG aren’t in the business of developing drugs through expensive trials and to the market, they get successful pre clinical data or phase 1 maybe 2 and sell it or like Juva get a deal to license it fro the bigger pharma to develop and take further. Our cash burn is extremely low and efficiently managed. All your posts are bigging yourself up and subtly trying to deramp.